Tops & Flops Stocks
| Security | Change (%) | 1w | 1m ▼ | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Intra-Cellular Therapies Inc. | -1.380% | 5.839% | 14.173% | 28.092% | 11.196% | 135.237% | 604.431% |
| Xeris Biopharma Holdings Inc. | -2.110% | 22.668% | 14.161% | 4.159% | 8.981% | -19.823% | - |
| Takara Bio Inc. | - | 4.839% | 14.035% | -38.679% | -15.584% | -69.626% | -62.428% |
| Medpace Holdings Inc | 2.060% | 10.535% | 14.018% | 93.410% | 49.359% | 170.774% | - |
| Ocuphire Pharma Inc. | -1.480% | 27.169% | 13.885% | -51.610% | -36.029% | -48.023% | - |
| Mochida Pharmaceutical Co. Ltd. | - | 1.587% | 13.609% | -4.950% | -6.796% | -29.927% | -49.738% |
| Evoke Pharma Inc. | -3.740% | 6.846% | 13.436% | -65.203% | -45.503% | -95.776% | -95.493% |
| Iovance Biotherapeutics Inc. | 9.900% | 23.938% | 13.363% | 25.014% | 10.605% | -54.738% | - |
| Aldeyra Therapeutics Inc. | 7.010% | 25.119% | 13.218% | -43.472% | 21.305% | -51.358% | - |
| Axsome Therapeutics Inc | 2.760% | 3.646% | 13.161% | 18.786% | 8.375% | 69.458% | - |
| Immuron | 5.830% | 20.442% | 12.953% | 30.539% | 30.539% | -42.932% | - |
| CEL-SCI Corp. | 20.200% | 21.282% | 12.935% | -40.783% | -47.209% | -79.611% | - |
| Corcept Therapeutics Inc. | -0.980% | 10.481% | 12.929% | 48.398% | 1.900% | 76.705% | - |
| Nanobiotix | -1.660% | -1.212% | 12.464% | -15.872% | -26.355% | -62.236% | -50.153% |
| Aclaris Therapeutics Inc | 2.820% | 4.754% | 12.386% | -86.872% | 29.895% | -89.943% | - |
| Celldex Therapeutics | -0.550% | 8.333% | 12.346% | 9.639% | 0.552% | 5.691% | 585.499% |
| Organigram Holdings Inc. | 3.320% | 12.342% | 12.342% | 11.096% | 24.186% | -81.276% | -93.210% |
| Oncotherapy Science Inc. | 10.830% | -2.247% | 12.258% | -16.346% | 33.846% | -78.250% | -80.114% |
| Arrowhead Pharmaceuticals Inc. | 4.000% | 15.614% | 12.169% | -12.298% | -3.764% | -49.610% | 7.646% |
| Blueprint Medicines Corp | 1.280% | 3.657% | 12.142% | 108.585% | 34.000% | 57.568% | - |
| Novavax Inc. | 9.240% | 37.466% | 11.989% | 94.598% | 237.245% | -90.480% | 278.961% |
| Arovella Therapeutics Ltd. | 3.470% | 2.874% | 11.875% | 280.851% | 32.593% | 203.390% | 258.000% |
| United Therapeutics | 0.630% | 0.871% | 11.854% | 45.622% | 51.828% | 91.720% | 342.647% |
| Genomma Lab International | -2.690% | 2.260% | 11.728% | 28.369% | 22.297% | 2.841% | 9.697% |
| Syndax Pharmaceuticals Inc | 3.060% | - | 11.702% | 7.692% | 12.299% | 52.174% | - |